Letters and urgent communications 2023 | Department of Health

Advice from the Chief Medical Officer to HSC professionals for 2023

Documents

HSS(MD) 31/2023 - Direct-acting oral anticoagulants (DOACs) paediatric formulations; reminder of dose adjustments in patients with renal impairment
PDF (146 KB)

HSS(MD) 30/2023 - Glucose solutions- recommendations to minimise the risks associated with the accidental use of glucose solutions instead of saline solutions in arterial lines
PDF (141 KB)

HSS(MD) 29/2023 - Febuxostat- updated advice for the treatment of patients with a history of major cardiovascular disease
PDF (164 KB)

HSS(MD)28/2023 - Covid-19 Vaccinations over the Summer of 2023
PDF (126 KB)

HSS(MD) 27 2023 - National Patient Safety Alert – Shortage of Pyridostigmine 60mg Tablets
PDF (172 KB)

HSS(MD) 26/2023 - Summary - Essure Contraceptive Devices
PDF (130 KB)

HSS(MD) 25/2023 - Nitrofurantoin - Reminder of the risks of Pulmonary and Hepatic adverse drug reactions
PDF (153 KB)

HSS(MD) 24/2023 Janus kinase (jak) inhibitors - new measures to reduce risks of major cardiovascular events, malignancy, venous thromboembolism, serious infections and increased mortality
PDF (171 KB)

HSS(MD) 23/2023 - End of the 2022/23 flu season and related issues
PDF (146 KB)

HSS(MD) 22/2023 - NCEPOD Report disordered activity a review of the quality of epilepsy care provided to adult patients presenting to hospital with a seizure
PDF (1 MB)

HSS(MD) 21/2023 - Isotretinoin (Roaccutane) new safety measures to be introduced in the coming months, including additional oversight on initiation of treatment for patients under 18 years
PDF (183 KB)

HSS(MD) 20/2023 - Covid-19 Treatments: Updated Independent Advisory Group Report of Highest Risk Groups
PDF (144 KB)

HSS(MD) 19 2023 Covid-19 Therapeutic Alert Publication of the Nice Multiple Technology Appraisal (MTA) – Treatment Recommendations for Covid -19
PDF (197 KB)

HSS (MD) 18/2023 - Updated Covid-19 testing guidance to support clinical pathways
PDF (150 KB)

HSS(MD) 17/2023 - UK Strategy for mpox (formerly known as monkeypox) control
PDF (234 KB)

HSS (MD) 16/2023 - Changes to the HPV Vaccination Schedule - Reduction to one dose
PDF (246 KB)

HSS(MD) 15/2023 - JCVI advice on 2023 Covid-19 Spring booster programme and significant changes to the primary course offer
PDF (170 KB)

HSS(MD) 14/2023 - Pholcodine: Drug Safety Update- Pholcodine-Containing Cough and Cold Medicines: Withdrawal from UK Market as a Precautionary Measure
PDF (151 KB)

HSS(MD)13/2023 - Guidance on the Revised Arrangements for the Cremation Process
PDF (191 KB)

HSS(MD) 11/2023 – Standards for the Abdominal Aortic Aneurysm Screening Programme
PDF (110 KB)

HSS(MD) 10/2023 – Standards for the Breast Cancer Screening Programme
PDF (149 KB)

HSS(MD) 09/2023 – Standards for the Diabetic Eye Screening Programme
PDF (78 KB)

HSS(MD) 08/2023 – Standards for the Newborn Blood Spot Screening Programme
PDF (78 KB)

HSS(MD) 07/2023 – Standards for the Newborn Hearing Screening Programme
PDF (77 KB)

HSS(MD) 6 2023 Palivizumab Passive Immunisation Against Respiratory Syncytial Virus (RSV) in at-risk pre-term Infants
PDF (124 KB)

HSS (MD) 5 2023 - JCVI Advice on 2023 Covid-19 Vaccination Programme
PDF (164 KB)

HSS MD 4 2023 - Prescribing of Unlicensed or Off-Label Medicines for the Management of Covid-19 or Post-Covid-19 Syndrome
PDF (127 KB)

HSS MD 3 2023 Supply of Licensed and Unlicensed Epidural Bags – National Patient Safety Alert
PDF (184 KB)

HSS(MD) 2/2023 - Changes to the HPV vaccination schedule
PDF (229 KB)

HSS(MD) 1/2023 - MBRRACE-UK perinatal mortality reports
PDF (210 KB)

Help viewing documents